Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Dyne Therapeutics

Youtube Subscribe

...

Ticker: DYN

Sector: Independent Power and Renewable Elect...

Dyne Therapeutics, Inc. focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company develops programs for myotonic dystrophy type 1, duchenne muscular dystroppy, and.
...
...
Extended Summary

Dyne Therapeutics

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Related Results

...
February 04, 2024 23:19 (London Time)

Dyne Therapeutics

Dyne Therapeutics (DYN, $21.04) Aroon Indicator entered an Uptrend on February 02, 2024. Dyne is developing modern oligonucleotide therapeutics.
Sector: Independent Power and Renewable E…
Ticker: DYN
Sentiment: 0.2263
MarketCap: 1,652,347,953.0
High: 22.22 Low: 20.4

Open: 22.09 Close: 21.04 Change: -1.05

Read more →
...
July 12, 2023 22:28 (London Time)

Dyne Therapeutics

Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ: DYN) from Outperform to Strong Buy. Raymond James raised the price target to $27 from $16.…
Sector: Independent Power and Renewable E…
Ticker: DYN
Sentiment: 0.8934
MarketCap: 687,483,188.0
High: 12.0 Low: 11.57

Open: 11.98 Close: 11.63 Change: -0.35

Read more →
Search
Happening Now
Categories